Pioglitazone safe and effective for treating T2DM in patients with NASH

被引：0
作者：
Tim Geach
机构：
来源：
Nature Reviews Endocrinology | 2016年 / 12卷 / 9期
关键词：
D O I：
10.1038/nrendo.2016.113
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：498 / 498
相关论文
共 50 条
  • [21] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Yan, Xueyu
    Si, Jinglei
    Zhong, Fangjie
    Wu, Yanjun
    Jiang, Qinyang
    Guo, Yafen
    Yang, Xiurong
    Liang, Jing
    Lan, Ganqiu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 236 - 244
  • [22] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Xueyu Yan
    Jinglei Si
    Fangjie Zhong
    Yanjun Wu
    Qinyang Jiang
    Yafen Guo
    Xiurong Yang
    Jing Liang
    Ganqiu Lan
    International Journal of Diabetes in Developing Countries, 2022, 42 : 236 - 244
  • [23] NASH: Pioglitazone is effective in Patients with and without Diabetes
    Bitzer, Michaela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (07):
  • [24] T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
    Thummasorn, Savitree
    Apichai, Sopida
    Chupradit, Supat
    Sirisattayawong, Pornpen
    Chaiwong, Pachpilai
    Sriwichaiin, Sirawit
    Pratchayasakul, Wasana
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    PLOS ONE, 2022, 17 (08):
  • [25] Treating T2DM by ensuring insulin access is a global challenge
    Horlyck-Romanovsky, Margrethe F.
    Sumner, Anne E.
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (03) : 135 - 137
  • [26] Effect of Liver Fat Accumulation on Insulin Resistance and Severity of NASH in Obese Patients with T2DM
    Lomonaco, Romina
    Orsak, Beverly
    Ortiz-Lopez, Carolina
    Chan, Janet
    Webb, Amy
    Cusi, Kenneth
    DIABETES, 2011, 60 : A454 - A454
  • [27] PROGRAM ACTIVE II: TREATING MAJOR DEPRESSION IN T2DM
    de Groot, Mary
    Hornsby, Guy
    Saha, Chandan K.
    Pillay, Yegan
    Fitzpatrick, Karen
    Mather, Kieren
    Shubrook, Jay
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1064 - S1065
  • [28] BUDGET IMPACT ANALYSIS OF VILDAGLIPTIN TREATING T2DM IN CHINA
    Fan, C. S.
    Guan, H. J.
    Wang, Y. N.
    VALUE IN HEALTH, 2016, 19 (03) : A200 - A200
  • [29] Treating T2DM by ensuring insulin access is a global challenge
    Margrethe F. Horlyck-Romanovsky
    Anne E. Sumner
    Nature Reviews Endocrinology, 2019, 15 : 135 - 137
  • [30] Clinical inertia—a barrier to effective management of T2DM
    Julie A. Lovshin
    Bernard Zinman
    Nature Reviews Endocrinology, 2013, 9 : 635 - 636
12345